Ads
related to: gsk
Search results
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks via Yahoo Finance· 2 days agoGSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling...
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
InvestorPlace· 2 days agoMany investors expected today’s move in GlaxoSmithKline (NYSE:GSK), with shares of GSK stock...
GSK Stock Slumps on Zantac Setback
The Wall Street Journal· 2 days agoGSK shares (UK:GSK, GSK) dropped after a state court in Delaware said it would allow more than 70,000 cases that allege its Zantac heartburn ...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Investing.com· 3 days agoShares in British drugmaker GSK fell sharply Monday following a Delaware judge's decision to allow...
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move...
Benzinga via AOL· 2 days agoOn Monday, GSK Plc (NYSE:GSK) shares were down after the Delaware State Court ruled that more than...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 1 day agoMonday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s ruling on 31 May that more...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 1 day agoUK-based pharmaceutical company GSK has reported updated results from a Phase II study of Jemperli...
GSK Plc ADR (NYSE: GSK): Performance Review And Forecast – Marketing Sentinel
Marketing Sentinel· 2 days agoIn today’s recent session, 6.61 million shares of the GSK Plc ADR (NYSE:GSK) have been traded, and its beta is 0.67. Most recently the company’s share price ...
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated...
Benzinga via Yahoo Finance· 2 days agoOn Sunday, GSK plc (NYSE:GSK) released results from an interim analysis of the DREAMM-8 phase 3...
